Tilray Inc (NASDAQ:TLRY – Get Free Report)’s stock price traded up 0.6% during trading on Monday . The company traded as high as $1.77 and last traded at $1.75. 3,857,347 shares changed hands during trading, a decline of 85% from the average session volume of 24,953,682 shares. The stock had previously closed at $1.74.
Tilray Stock Performance
The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.42 and a current ratio of 2.27. The firm has a market capitalization of $1.30 billion, a P/E ratio of -3.78 and a beta of 2.13. The firm has a 50 day moving average price of $1.79 and a two-hundred day moving average price of $1.88.
Tilray (NASDAQ:TLRY – Get Free Report) last announced its earnings results on Monday, July 29th. The company reported ($0.04) EPS for the quarter, missing the consensus estimate of ($0.02) by ($0.02). The company had revenue of $229.90 million for the quarter, compared to analysts’ expectations of $226.20 million. Tilray had a negative net margin of 30.26% and a negative return on equity of 2.63%. The company’s revenue for the quarter was up 24.8% on a year-over-year basis. During the same period in the prior year, the company earned ($0.15) earnings per share. On average, equities research analysts expect that Tilray Inc will post -0.16 EPS for the current fiscal year.
Hedge Funds Weigh In On Tilray
Tilray Company Profile
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Featured Stories
- Five stocks we like better than Tilray
- Why Invest in High-Yield Dividend Stocks?
- S&P 500 Hitting Resistance: These 3 Stocks Offer the Best Upside
- How to Calculate Return on Investment (ROI)
- Nike’s Post-Earnings Drop Presents a Buying Opportunity
- How to Use the MarketBeat Excel Dividend Calculator
- Microsoft’s Targeted Upside Might Be Too Good to Ignore
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.